«
»

Top

Cancer Cells Destroyed With Two Antipsychotic Drugs

Jul 26, 2018

Cancer Cells Destroyed With Two Antipsychotic Drugs

Some cancers survive on high cholesterol levels. New research uses antipsychotic drugs to "starve" these cancer cells of cholesterol.

Cell culture experiments showed that two antypsychotics can effectively destroy cancer cells.
Some studies have shown that certain malignancies depend on cholesterol to survive, and that high serum cholesterol levels can predict the risk of cancer.

Moreover, a drug compound called leelaminehas been shown in recent studies to delay tumor growth in melanoma, which is a dangerous form of skin cancer.

Based on this research, scientists at the Pennsylvania State (Penn State) University Cancer Institute in Hershey — led by Omer Kuzu, a postdoctoral fellow in pharmacology — set out to stop the movement of cholesterol within treatment-resistant cancer cells.

To do so, they turned to a class of drugs called functional inhibitors of acid sphingomyelinase (FIASMAs). Specifically, they tested 42 FIASMAs that were either antipsychotics or antidepressantsand compared their effects with those of leelamine.

The findings were published in the British Journal of Cancer.

Using nanoparticles to deliver perphenazine

Kuzu and colleagues tested the drugs first in cell cultures, and then in mouse models of melanoma.

Of all the 42 drugs tested, perphenazine and fluphenazine were found to be just as effective as leelamine at killing cancer cells.

Then, the researchers administered these drugs orally to mice. They monitored the size and weight of the rodents' tumors.

Perphenazine reduced the size and weight of the malignancies, but only in high doses. Such a dosage made the rodents sleepy.

"Perphenazine was able to decrease tumor growth by shutting down cholesterol metabolism in cancer cells," explains lead study author Kuzu. "But the problem was that the drug concentrations required to do so led to sedative effects and loss of animal weight since mice were sleeping and not eating."

To bypass these side effects, the scientists used nanoparticles made of lipids, or fats, called nanoliposomes to deliver the drug.

Administered intravenously, these mini drug carriers destroyed the tumors without causing as many side effects. This was because the nanoparticles cannot permeate the blood-brain barrier, unlike the oral drugs.

"This study suggests that disruption of intracellular cholesterol transport by targeting ASM [acid sphingomyelinase] could be utilized as a potential chemotherapeutic approach for treating cancer," conclude the authors.

Earlier this month, Medical News Today reported on another study that found that a defunct antipsychotic drug can enhance chemotherapy.

Senior study author Gavin Robertson, the director of the Penn State Melanoma and Skin Cancer Center, comments on the findings, saying, "This drug could be the first of a new class, disrupting the movement of cholesterol in cancer cells to inhibit disease development."

It could lead to the repurposing of perphenazine to perform a new function in human medicine by encapsulating it into a nanoparticle, which reduces its capability of entering the brain so it can perform its new function to prevent cancer." - Gavin Robertson.

The scientists note that previous trials have tested the effects of antipsychotics in the fight against different types of cancer, but the results have been mixed.

Delivering the drugs via nanoliposomes could make the compounds safer and more effective.

Medical News Today

Comments

You will also like

Cancer diagnosis: Carenity members tell their story

Acute lymphoid leukemia
Acute myeloid leukemia
Adamantinoma
Anal cancer
Astrocytoma
Basal cell carcinoma
Bladder cancer
Bone cancer
Brain tumor
Breast cancer
Cancer of the Pleura
Cancer of the vulva
Cervical cancer
Chordoma
Choriocarcinoma
Chronic lymphocytic leukemia
Chronic myeloid leukemia
Colorectal cancer
Dermatofibrosarcoma protuberans
Endometrial cancer
Enteropancreatic endocrine tumor
Esophageal cancer
Ewing sarcoma
Extraskeletal myxoid chondrosarcoma
Gallbladder cancer
Gastric cancer
Gastrointestinal stromal tumor
Glial tumor
Glioblastoma
Hodgkin lymphoma
Kaposi sarcoma
Larynx cancer
Liver cancer
Lung cancer
Malignant tumor of the fallopian tube
Merkel tumor
Mesothelioma
Mouth cancer
Multiple endocrine neoplasia
Multiple myeloma
Myelodysplastic syndromes
Myelofibrosis
Nasopharyngeal cancer
Nephroblastoma
Neuroblastoma
Neuroendocrine tumor
Non-Hodgkin lymphoma
Ovarian cancer
Palate cancer
Pancreatic cancer
Parotid cancer
Pheochromocytoma
Primary peritoneal tumor
Prostate cancer
Renal cancer
Retinoblastoma
Rhabdoid tumor
Sézary syndrome
Skin cancer
Squamous cell carcinoma of head and neck
Testicular cancer
Throat cancer
Thymus cancer
Thyroid Cancer
Tongue cancer
Tonsil cancer
Vaginal Cancer
Waldenström macroglobulinemia

Cancer diagnosis: Carenity members tell their story

Read the article
Crohn's Disease diagnosis: Carenity members tell their story

Crohn's disease

Crohn's Disease diagnosis: Carenity members tell their story

Read the article
Our guide to getting the most out of doctor's appointments

Our guide to getting the most out of doctor's appointments

Read the article
Sleeping disturbances: when and how to treat them?

Sleeping disturbances: when and how to treat them?

Read the article